Home / Services / Synthetic Biology Chassis Development / Bacterial Chassis Engineering / E.coli Genome Editing & Metabolic Engineering Services / E. coli Genome Editing Services / E. coli Base Editing and Precision Genome Engineering Services

E. coli Base Editing and Precision Genome Engineering Services

Single-Nucleotide Precision Without Double-Strand Breaks. In microbial metabolic engineering and synthetic biology, traditional gene knockouts often lead to drastic phenotypic changes. CD Biosynsis provides high-efficiency base conversion services for Escherichia coli leveraging cutting-edge CRISPR base editing technologies. We enable precise C-to-T and A-to-G transitions, as well as simultaneous multi-site editing, without generating DNA double-strand breaks (DSBs). Our platform is a powerful tool for in situ protein evolution and the fine-tuning of metabolic pathways.

Get a Technical Quote
Services Offered Integrated Workflow Application Studies Key Advantages FAQs

Comprehensive Services Offered

Our platform provides more than just standard single-base substitutions; we offer comprehensive solutions for complex genomic screening and versatile editing, including substitutions, deletions, and insertions at single-nucleotide resolution.

Service Tier Technical Strategy Best For Standard Deliverables
CBE / ABE Service Cytosine/Adenine Base Editors Targeted C-to-T or A-to-G substitutions 2 Validated stocks + Sanger/NGS report
Dual Base Editing iACBEs (Improved Dual BEs) Simultaneous C-to-T and A-to-G mutations Multi-point mutant strains + Validation data
Prime Editing CRISPR-Prime Editing Platform Small insertions, deletions, and substitutions Precision-edited strains + Sequence data
High-Throughput Screen Base Editing Genetic Screens Mapping genotype-to-phenotype relationships Mutant library + Enrichment analysis report

Integrated Workflow

E. coli precision base editing service workflow

1. Bioinformatic Design

2. Editor Selection

3. Strain Transformation

4. Validation & Delivery

Identification of the editing window and design of high-efficiency sgRNAs or pegRNAs with minimal off-target risk.

Formal project proposal and Mutual NDA signing.

Choosing the most suitable deaminase (CBE/ABE) or Prime Editor construct based on the modification.

Synthesis of optimized editor components.

Introduction of editing components into the target E. coli host.

Induced base conversion and curing of editing plasmids.

Verification of editing efficiency and monoclonal purity via Sanger sequencing or deep NGS.

Final QC report delivery with mutational frequency analysis.

Application Studies: Technical Benchmarks in E. coli

To provide the highest level of service, our team continuously benchmarks our internal protocols against landmark studies in the field of E. coli precision editing.

High-Throughput Screen Prime Editing Toolkit Dual Base Conversion

Application Study 1: High-Throughput Base Editing Genetic Screens

For genome-wide phenotypic discovery, we reference the latest CRISPR base editing screening frameworks. By constructing large-scale mutant libraries in E. coli, we can rapidly elucidate complex genotype-to-phenotype relationships, providing a roadmap for industrial strain evolution.
(Reference: Gawlitt et al., Nucleic Acids Research)

Application Study 2: Versatile Prime Editing Toolkit

Traditional base editing is restricted to specific transition types. We integrate prokaryotic Prime Editing logic to perform high-fidelity replacements, insertions, and deletions on the E. coli chromosome, achieving single-base resolution with high accuracy.
(Reference: Tong et al., Nature Communications)

Application Study 3: Simultaneous A & C Conversion (iACBEs)

For in situ protein evolution, we apply improved dual base editor (iACBE) systems. These combine highly active deaminase variants to generate synchronized base modifications, providing unprecedented mutational coverage for the discovery of novel protein functions.
(Reference: Shelake et al., mBio)

Key Advantages

  • DSB-free Technology: Editing occurs without double-strand breaks, significantly reducing cell lethality and maintaining genomic integrity.
  • Single-Nucleotide Resolution: True single-base tuning without altering surrounding sequences, preserving endogenous regulatory logic.
  • Enhanced Selectivity: Evolved deaminase variants favor precise transitions, providing cleaner results with low off-target activity.
  • IP Ownership: All projects are protected by a Mutual NDA. Strains are 100% owned by the client.

FAQs About E. coli Base Editing

Ready for surgical-precision engineering?

Contact Us

1. What is the typical effective editing window?

The editing window is typically located between 4–20 bp upstream of the PAM sequence. Our iACBE system provides broad coverage from positions 6 to 15.

2. Does this technology leave a scar or marker in the genome?

No. Base editing works by chemically modifying the existing base, resulting in a scarless transition without foreign DNA or resistance markers.

3. Can you edit multiple sites simultaneously?

Yes. Using multi-guide RNA strategies, we can target 2–3 sites at once, depending on the specific loci and target window.

4. How does base editing differ from traditional CRISPR knockouts?

Traditional knockouts rely on Indels causing frame shifts. Base editing allows for subtler changes, such as introducing a STOP codon or modifying a single critical amino acid.

5. How do you assess off-target effects?

We use bioinformatic prediction tools during design and provide deep NGS sequencing of target regions to ensure no unintended base changes occurred.

Scientific References

  1. Gawlitt, S., et al. (2024). Expanding the flexibility of base editing for high-throughput genetic screens in bacteria. Nucleic Acids Research.
  2. Tong, Y., et al. (2021). A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing. Nature Communications.
  3. Shelake, R. M., et al. (2023). Improved Dual Base Editor Systems (iACBEs) for Simultaneous Conversion of Adenine and Cytosine in the Bacterium Escherichia coli. mBio.
  4. Neugebauer, M. E., et al. (2022). Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nature Biotechnology.